FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3185020970> ?p ?o ?g. }

• W3185020970 endingPage "270" @default.
• W3185020970 startingPage "262" @default.
• W3185020970 abstract "Objective: In this case report, we aimed to examine the effects of an intensive voice treatment (the Lee Silverman Voice Treatment [LSVT®LOUD]) for Wilson’s disease (WD), and adult cerebral palsy (CP), and dysarthria.Method: The participants received LSVT®LOUD four times a week for 4 weeks. Acoustic, perceptual (GRBAS) analyses were performed and data from the Voice Handicap Index (VHI) were obtained before and after treatment.Results: Besides the Harmonics-to Noise Ratio (HNR) value (dB) of the participant with WD, for both participants’ fundamental frequencies (Hz), jitter (%), and shimmer (%) values showed significant differences (p < .05) after therapy. Both participants showed significant improvements (p < .05) in the duration (s) and the sound pressure level (dB, SPL) of sustained vowel phonation (/a/), in SPL (dB) of pitch range (high and low /a/) and reading and conversation (p < .01). There was a positive improvement in the high-frequency values (Hz) of both participants but not in the low-frequency values (Hz) in the participant with WD. Perceptual analysis with GRBAS judgements of sustained vowel (/a/) and paragraph reading of two participants also showed improvement. After therapy, perceived loudness of the participants’ voice increased.Conclusions: The findings provide some preliminary observations that the individuals with WD and the adult individuals with CP can respond positively to intensive speech treatment such as LSVT®LOUD. Further studies are needed to investigate speech treatments specific to WD and adult CP." @default.
• W3185020970 created "2021-08-02" @default.
• W3185020970 creator A5005705969 @default.
• W3185020970 creator A5034940498 @default.
• W3185020970 creator A5035396980 @default.
• W3185020970 creator A5040409288 @default.
• W3185020970 creator A5044678970 @default.
• W3185020970 creator A5089054289 @default.
• W3185020970 date "2021-07-21" @default.
• W3185020970 modified "2023-10-17" @default.
• W3185020970 title "Intensive voice treatment (the Lee Silverman Voice Treatment [LSVT^®LOUD]) for individuals with Wilson’s disease and adult cerebral palsy: two case reports" @default.
• W3185020970 cites W1034989945 @default.
• W3185020970 cites W1587735356 @default.
• W3185020970 cites W1615535080 @default.
• W3185020970 cites W1900154594 @default.
• W3185020970 cites W1964143171 @default.
• W3185020970 cites W1964546269 @default.
• W3185020970 cites W1968538791 @default.
• W3185020970 cites W1968914381 @default.
• W3185020970 cites W1976571598 @default.
• W3185020970 cites W1980322283 @default.
• W3185020970 cites W1984408005 @default.
• W3185020970 cites W1985366957 @default.
• W3185020970 cites W1987249044 @default.
• W3185020970 cites W1987895062 @default.
• W3185020970 cites W1992660316 @default.
• W3185020970 cites W1995516199 @default.
• W3185020970 cites W1998034600 @default.
• W3185020970 cites W1998362980 @default.
• W3185020970 cites W2003265842 @default.
• W3185020970 cites W2003569243 @default.
• W3185020970 cites W2006277158 @default.
• W3185020970 cites W2006409386 @default.
• W3185020970 cites W2008252714 @default.
• W3185020970 cites W2010805363 @default.
• W3185020970 cites W2017854968 @default.
• W3185020970 cites W2018930296 @default.
• W3185020970 cites W2023440302 @default.
• W3185020970 cites W2024521522 @default.
• W3185020970 cites W2025058112 @default.
• W3185020970 cites W2025386793 @default.
• W3185020970 cites W2026336686 @default.
• W3185020970 cites W2028394234 @default.
• W3185020970 cites W2034335217 @default.
• W3185020970 cites W2034517188 @default.
• W3185020970 cites W2038555044 @default.
• W3185020970 cites W2044110840 @default.
• W3185020970 cites W2049581078 @default.
• W3185020970 cites W2052410075 @default.
• W3185020970 cites W2056233072 @default.
• W3185020970 cites W2059715902 @default.
• W3185020970 cites W2065097374 @default.
• W3185020970 cites W2067965621 @default.
• W3185020970 cites W2072378349 @default.
• W3185020970 cites W2076427189 @default.
• W3185020970 cites W2080058161 @default.
• W3185020970 cites W2084243422 @default.
• W3185020970 cites W2087463191 @default.
• W3185020970 cites W2087484885 @default.
• W3185020970 cites W2088744964 @default.
• W3185020970 cites W2091260974 @default.
• W3185020970 cites W2091954768 @default.
• W3185020970 cites W2093926289 @default.
• W3185020970 cites W2103441272 @default.
• W3185020970 cites W2103589991 @default.
• W3185020970 cites W2110575642 @default.
• W3185020970 cites W2111447855 @default.
• W3185020970 cites W2113249453 @default.
• W3185020970 cites W2132710264 @default.
• W3185020970 cites W2140403296 @default.
• W3185020970 cites W2166292372 @default.
• W3185020970 cites W2169541679 @default.
• W3185020970 cites W2325550631 @default.
• W3185020970 cites W2553529407 @default.
• W3185020970 cites W2605776452 @default.
• W3185020970 cites W2734550951 @default.
• W3185020970 cites W2788835759 @default.
• W3185020970 cites W2796161277 @default.
• W3185020970 cites W289460496 @default.
• W3185020970 cites W2898391292 @default.
• W3185020970 cites W2903148682 @default.
• W3185020970 cites W2921354068 @default.
• W3185020970 cites W2923975383 @default.
• W3185020970 cites W2973515423 @default.
• W3185020970 cites W3007033528 @default.
• W3185020970 cites W3029883987 @default.
• W3185020970 cites W3037792587 @default.
• W3185020970 cites W4211041131 @default.
• W3185020970 cites W4232586459 @default.
• W3185020970 cites W4235523722 @default.
• W3185020970 doi "https://doi.org/10.1080/14015439.2021.1951348" @default.
• W3185020970 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34287100" @default.
• W3185020970 hasPublicationYear "2021" @default.
• W3185020970 type Work @default.
• W3185020970 sameAs 3185020970 @default.
• W3185020970 citedByCount "1" @default.
• W3185020970 countsByYear W31850209702023 @default.
• W3185020970 crossrefType "journal-article" @default.

• next